News
RANI
7.55
-0.13%
-0.01
Rani Therapeutics Holdings (RANI) Gets a Buy from Stifel Nicolaus
TipRanks · 2h ago
Rani Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 3h ago
Rani Therapeutics Price Target Raised to $13.00/Share From $12.00 by HC Wainwright & Co.
Dow Jones · 3h ago
HC Wainwright & Co. Maintains Buy on Rani Therapeutics Hldgs, Raises Price Target to $13
Benzinga · 4h ago
RANI THERAPEUTICS HOLDINGS, INC. <RANI.O>: H.C. WAINWRIGHT RAISES TARGET PRICE TO $13 FROM $12
Reuters · 4h ago
U.S. RESEARCH ROUNDUP- Perficient, Target, Vertex Pharmaceuticals
Wall Street analysts revise their ratings and price targets on several U.S.-listed companies. Perficient, Target, Vertex Pharmaceuticals, Cardinal Health added to list of companies with positive research actions. Analysts cut ratings and target prices on several companies on Tuesday.
Reuters · 7h ago
RANI Stock Earnings: Rani Therapeutics Hldgs Beats EPS for Q1 2024
Rani Therapeutics Hldgs reported earnings per share of -29 cents for the first quarter of 2024. The company did not report any revenue for the quarter. This was above the analyst estimate for EPS of -31 cents. Rani Therapedics reported results for the fourth quarter of 2016.
Investorplace · 12h ago
Rani Therapeutics Holdings, Inc. Quarterly Report
Press release · 17h ago
Rani Therapeutics Hldgs Q1 EPS $(0.29) Beats $(0.31) Estimate
Benzinga · 18h ago
RANI THERAPEUTICS HOLDINGS: QTRLY NET LOSS PER CLASS A COMMON SHARE ATTRIBUTABLE TO RANI THERAPEUTICS HOLDINGS, BASIC & DILUTED $0.29
Reuters · 18h ago
Weekly Report: what happened at RANI last week (0429-0503)?
Weekly Report · 1d ago
Weekly Report: what happened at RANI last week (0422-0426)?
Weekly Report · 04/29 10:52
Weekly Report: what happened at RANI last week (0415-0419)?
Weekly Report · 04/22 10:44
BGC, DRS and AMTX are among after hour movers
Seeking Alpha · 04/19 21:56
Equifax Reports Weak Sales, Joins Synovus Financial And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Shares of Equifax Inc. Fell sharply in today’s pre-market trading. The company reported worse-than-expected first-quarter sales results and issued adjusted guidance below estimates. Funko, Inc. And Rani Therapeutics Holdings also recorded losses.
Benzinga · 04/18 13:03
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
The Travelers Companies, Inc. Shares dipped 8.1% to $205.03 on Wednesday. Travelers reported a mixed first quarter, with earnings lagging analyst' expectations. InVO Bioscience shares shot up 256% after the company reported a year-over-year increase in fourth-quarter revenue.
Benzinga · 04/17 17:36
12 Health Care Stocks Moving In Wednesday's Intraday Session
INVO Bioscience stock rose 275.0% to $2.85 during Wednesday's regular session. The company's Q4 earnings report came out yesterday. Vanda Pharma stock moved upwards by 33.33% during the session. Losers include Longeveron (NASDAQ:LGVN) and Dare BiosScience.
Benzinga · 04/17 16:31
Weekly Report: what happened at RANI last week (0408-0412)?
Weekly Report · 04/15 10:38
12 Health Care Stocks Moving In Friday's Intraday Session
PaxMedica stock increased by 110.9% to $0.87 during Friday's regular session. Q32 Bio (NASDAQ:QTTB) shares rose 23.89% during the session. Cyclacel Pharmaceuticals shares increased by 20.45%. SenesTech and Motus GI Hldgs were among the losers.
Benzinga · 04/12 16:31
Weekly Report: what happened at RANI last week (0401-0405)?
Weekly Report · 04/08 10:41
More
Webull provides a variety of real-time RANI stock news. You can receive the latest news about Rani Therapeutics Holdings, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About RANI
Rani Therapeutics Holdings, Inc. is a clinical-stage biotherapeutics company. The Company is focused on advancing technologies to enable the administration of biologics and drugs orally, to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. It has developed a drug-agnostic oral delivery platform, the RaniPill capsule, which is designed to deliver a variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. The RaniPill GO, is designed to deliver up to a three micrograms (mg) dose of drug with high bioavailability. The capsule includes a coating designed to withstand stomach acid but dissolve in the jejunum portion of the small intestine. Its pipeline includes RT-102, RT-105, RT-111 and RT-110. It is also developing a high-capacity version of the RaniPill capsule known as the RaniPill HC, which is intended to enable delivery of drug payloads up to 200uL in liquid form with high bioavailability.